[시장보고서]유방 영상 진단용 AI 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 경쟁별, 영상 진단법별, 용도별, 최종 용도별, 지역별, 경쟁별(2020-2030년)

유방 영상 진단용 AI 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 경쟁별, 영상 진단법별, 용도별, 최종 용도별, 지역별, 경쟁별(2020-2030년)

AI In Breast Imaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component, By Imaging Modality, By Application, By End Use, By Region and Competition, 2020-2030F

상품코드 : 1667939

리서치사 : TechSci Research

발행일 : 2025년 02월

페이지 정보 : 영문 182 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,385,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 7,805,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,352,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

세계의 유방 영상 진단용 AI 시장 규모는 2024년 3억 2,032만 달러로, 예측 기간 중 5.47%의 연평균 복합 성장률(CAGR)로 2030년에는 4억 4,198만 달러에 달할 것으로 예상됩니다.

AI 기술, 특히 딥러닝 알고리즘은 이미지 분석을 개선하고 인적 오류를 줄이며 진단 속도를 향상시킴으로써 진단 프로세스에 혁명을 일으키고 있습니다. 진단 프로세스에 혁명을 가져오고 있습니다. 이러한 발전은 종양과 이상을 보다 정확하게 감지할 수 있게 하여 환자의 예후를 개선하는 데 도움이 됩니다. 유방암 유병률 증가는 디지털 이미징 기술의 채택 증가와 함께 시장 확대에 기여하고 있습니다. 유방촬영술, 초음파 등 다른 의료 영상 진단 기법과 AI의 통합은 시장 잠재력을 더욱 높여주고 있습니다. 의료 시스템이 개인화되고 효율적인 치료를 우선시함에 따라 유방 영상 진단용 AI의 역할은 더욱 확대될 것으로 예상됩니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	3억 2,032만 달러
시장 규모 : 2030년	4억 4,198만 달러
CAGR: 2025-2030년	5.47%
급성장 부문	소프트웨어
최대 시장	북미

시장 성장 촉진요인

유방암 발병률 증가

주요 시장 이슈

데이터 프라이버시 및 보안에 대한 우려

주요 시장 동향

조기 발견 및 검진에 대한 수요 증가

시장 규모·예측
- 금액별
시장 점유율·예측
- 컴포넌트별(하드웨어와 소프트웨어)
- 영상 진단법별(맘모그래피, 초음파 영상 진단, MRI)
- 용도별(스크리닝, 진단, 영상 유도 생검)
- 최종 용도별(병원·진료소, 진단 영상 센터, 조사기관)
- 지역별
- 기업별(2024년)
시장 맵

제6장 북미의 유방 영상 진단용 AI 시장 전망

시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
- 캐나다
- 멕시코

제7장 유럽의 유방 영상 진단용 AI 시장 전망

시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
- 영국
- 이탈리아
- 프랑스
- 스페인

제8장 아시아태평양의 유방 영상 진단용 AI 시장 전망

시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
- 인도
- 일본
- 한국
- 호주

제9장 남미의 유방 영상 진단용 AI 시장 전망

시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
- 아르헨티나
- 콜롬비아

제10장 중동 및 아프리카의 유방 영상 진단용 AI 시장 전망

시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
- 사우디아라비아
- 아랍에미리트

제11장 시장 역학

촉진요인
과제

제12장 시장 동향과 발전

합병과 인수(해당하는 경우)
제품의 발매(해당하는 경우)
최근 동향

제13장 Porter's Five Forces 분석

업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협

제14장 경쟁 구도

Visage Imaging, Inc.
CureMetrix, Inc.
DeepHealth, Inc.
GE HealthCare Technologies Inc.
Hologic, Inc.
Siemens Healthineers AG
Fujifilm Holdings Corporation
Koninklijke Philips N.V.
iCAD, Inc.
Medicalgorithmics SA

제15장 전략적 제안

제16장 조사회사 소개·면책사항

KSA

영문 목차

영문목차

Global AI in Breast Imaging Market was valued at USD 320.32 Million in 2024 and is expected to reach USD 441.98 Million by 2030 with a CAGR of 5.47% during the forecast period. The global AI in breast imaging market is experiencing significant growth, driven by the increasing demand for early and accurate breast cancer detection. AI technologies, particularly deep learning algorithms, are revolutionizing the diagnostic process by improving image analysis, reducing human error, and enhancing the speed of diagnosis. These advancements allow for more precise detection of tumors and abnormalities, leading to better patient outcomes. The growing prevalence of breast cancer, along with the rise in the adoption of digital imaging technologies, is contributing to the market's expansion. The integration of AI with other medical imaging modalities, such as mammography and ultrasound, further enhances the market potential. As healthcare systems increasingly prioritize personalized and efficient care, AI's role in breast imaging is expected to continue growing.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 320.32 Million
Market Size 2030	USD 441.98 Million
CAGR 2025-2030	5.47%
Fastest Growing Segment	Software
Largest Market	North America

Key Market Drivers

Increasing Incidence of Breast Cancer

Breast cancer continues to be one of the most prevalent types of cancer worldwide, with millions of new cases diagnosed annually. The rising incidence of breast cancer is primarily attributed to lifestyle changes, aging populations, and environmental factors. According to the American Cancer Society, breast cancer is the second leading cause of cancer deaths among women in the United States. As the incidence of breast cancer increases, so does the need for improved diagnostic methods to detect the disease at the earliest possible stage. Early detection is critical for improving prognosis, as it allows for more effective treatment options and a higher chance of survival. According to WHO, in 2022, breast cancer led to approximately 670,000 deaths worldwide. Around half of all breast cancer cases occur in women with no distinct risk factors other than their sex and age. It was the most common cancer among women in 157 out of 185 countries that year. Breast cancer affects individuals globally, with occurrences in every country. While predominantly a women's disease, about 0.5-1% of breast cancer cases are found in men.

Key Market Challenges

Data Privacy and Security Concerns

As with any technology that deals with sensitive healthcare data, AI in breast imaging faces significant challenges related to data privacy and security. Breast imaging datasets often contain highly personal medical information, and the need to protect this data from unauthorized access or breaches is paramount. Healthcare providers, hospitals, and tech companies developing AI tools must ensure compliance with stringent data protection regulations, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States, the General Data Protection Regulation (GDPR) in Europe, and other regional laws.

Key Market Trends

Growing Demand for Early Detection and Screening

The global healthcare industry is increasingly prioritizing early detection, and breast cancer screening is no exception. The earlier breast cancer is detected, the higher the likelihood of successful treatment and improved survival rates. Consequently, early detection technologies are a significant focus for healthcare systems worldwide. Routine screenings, such as mammograms, are now widely recommended for women above a certain age or those with higher risk factors, such as family history or genetic predispositions. Early screening not only helps identify cancer in its most treatable stages but also lowers overall healthcare costs by preventing the need for more aggressive treatments that are required for late-stage cancers.

All leading medical organizations in the US recommend screening mammography for women aged 40 and above. Studies have shown that screening mammography reduces breast cancer mortality by approximately 20% to 35% in women aged 50 to 69, and by a slightly lower percentage in women aged 40 to 49, with a 14-year follow-up. Despite the effectiveness of mammograms and other imaging techniques, there are challenges in detecting early-stage tumors, particularly in women with dense breast tissue, where mammograms are less sensitive. AI-powered tools can help overcome this limitation by improving image clarity, identifying cancerous areas more accurately, and providing additional insights to clinicians. AI algorithms are trained to detect early-stage cancers that might be missed in a routine manual review of mammograms, reducing the risk of false negatives.

Key Market Players

Visage Imaging, Inc.
CureMetrix, Inc.
DeepHealth, Inc.
GE HealthCare Technologies Inc.
Hologic, Inc.
Siemens Healthineers AG
Fujifilm Holdings Corporation
Koninklijke Philips N.V.
iCAD, Inc.
Medicalgorithmics SA

Report Scope:

In this report, the Global AI In Breast Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

AI In Breast Imaging Market, By Component:

Hardware
Software

AI In Breast Imaging Market, By Imaging Modality:

Mammography
Ultrasound Imaging
MRI

AI In Breast Imaging Market, By Application:

Screening
Diagnostics
Image-guided Biopsy

AI In Breast Imaging Market, By End Use:

Hospitals & Clinics
Diagnostic Imaging Centers
Research Institutes

AI In Breast Imaging Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global AI In Breast Imaging Market.

Available Customizations:

Global AI In Breast Imaging market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global AI In Breast Imaging Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Component (Hardware and Software)
- 5.2.2. By Imaging Modality (Mammography, Ultrasound Imaging, and MRI)
- 5.2.3. By Application (Screening, Diagnostics, and Image-guided Biopsy)
- 5.2.4. By End Use (Hospitals & Clinics, Diagnostic Imaging Centers, and Research Institutes)
- 5.2.5. By Region
- 5.2.6. By Company (2024)
5.3. Market Map

6. North America AI In Breast Imaging Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Component
- 6.2.2. By Imaging Modality
- 6.2.3. By Application
- 6.2.4. By End Use
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States AI In Breast Imaging Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Component
    - 6.3.1.2.2. By Imaging Modality
    - 6.3.1.2.3. By Application
    - 6.3.1.2.4. By End Use
- 6.3.2. Canada AI In Breast Imaging Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Component
    - 6.3.2.2.2. By Imaging Modality
    - 6.3.2.2.3. By Application
    - 6.3.2.2.4. By End Use
- 6.3.3. Mexico AI In Breast Imaging Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Component
    - 6.3.3.2.2. By Imaging Modality
    - 6.3.3.2.3. By Application
    - 6.3.3.2.4. By End Use

7. Europe AI In Breast Imaging Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Component
- 7.2.2. By Imaging Modality
- 7.2.3. By Application
- 7.2.4. By End Use
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany AI In Breast Imaging Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Component
    - 7.3.1.2.2. By Imaging Modality
    - 7.3.1.2.3. By Application
    - 7.3.1.2.4. By End Use
- 7.3.2. United Kingdom AI In Breast Imaging Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Component
    - 7.3.2.2.2. By Imaging Modality
    - 7.3.2.2.3. By Application
    - 7.3.2.2.4. By End Use
- 7.3.3. Italy AI In Breast Imaging Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Component
    - 7.3.3.2.2. By Imaging Modality
    - 7.3.3.2.3. By Application
    - 7.3.3.2.4. By End Use
- 7.3.4. France AI In Breast Imaging Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Component
    - 7.3.4.2.2. By Imaging Modality
    - 7.3.4.2.3. By Application
    - 7.3.4.2.4. By End Use
- 7.3.5. Spain AI In Breast Imaging Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Component
    - 7.3.5.2.2. By Imaging Modality
    - 7.3.5.2.3. By Application
    - 7.3.5.2.4. By End Use

8. Asia-Pacific AI In Breast Imaging Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Component
- 8.2.2. By Imaging Modality
- 8.2.3. By Application
- 8.2.4. By End Use
- 8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China AI In Breast Imaging Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Component
    - 8.3.1.2.2. By Imaging Modality
    - 8.3.1.2.3. By Application
    - 8.3.1.2.4. By End Use
- 8.3.2. India AI In Breast Imaging Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Component
    - 8.3.2.2.2. By Imaging Modality
    - 8.3.2.2.3. By Application
    - 8.3.2.2.4. By End Use
- 8.3.3. Japan AI In Breast Imaging Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Component
    - 8.3.3.2.2. By Imaging Modality
    - 8.3.3.2.3. By Application
    - 8.3.3.2.4. By End Use
- 8.3.4. South Korea AI In Breast Imaging Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Component
    - 8.3.4.2.2. By Imaging Modality
    - 8.3.4.2.3. By Application
    - 8.3.4.2.4. By End Use
- 8.3.5. Australia AI In Breast Imaging Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Component
    - 8.3.5.2.2. By Imaging Modality
    - 8.3.5.2.3. By Application
    - 8.3.5.2.4. By End Use

9. South America AI In Breast Imaging Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Component
- 9.2.2. By Imaging Modality
- 9.2.3. By Application
- 9.2.4. By End Use
- 9.2.5. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil AI In Breast Imaging Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Component
    - 9.3.1.2.2. By Imaging Modality
    - 9.3.1.2.3. By Application
    - 9.3.1.2.4. By End Use
- 9.3.2. Argentina AI In Breast Imaging Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Component
    - 9.3.2.2.2. By Imaging Modality
    - 9.3.2.2.3. By Application
    - 9.3.2.2.4. By End Use
- 9.3.3. Colombia AI In Breast Imaging Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Component
    - 9.3.3.2.2. By Imaging Modality
    - 9.3.3.2.3. By Application
    - 9.3.3.2.4. By End Use

10. Middle East and Africa AI In Breast Imaging Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Component
- 10.2.2. By Imaging Modality
- 10.2.3. By Application
- 10.2.4. By End Use
- 10.2.5. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa AI In Breast Imaging Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Component
    - 10.3.1.2.2. By Imaging Modality
    - 10.3.1.2.3. By Application
    - 10.3.1.2.4. By End Use
- 10.3.2. Saudi Arabia AI In Breast Imaging Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Component
    - 10.3.2.2.2. By Imaging Modality
    - 10.3.2.2.3. By Application
    - 10.3.2.2.4. By End Use
- 10.3.3. UAE AI In Breast Imaging Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Component
    - 10.3.3.2.2. By Imaging Modality
    - 10.3.3.2.3. By Application
    - 10.3.3.2.4. By End Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Visage Imaging, Inc.
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. CureMetrix, Inc.
14.3. DeepHealth, Inc.
14.4. GE HealthCare Technologies Inc.
14.5. Hologic, Inc.
14.6. Siemens Healthineers AG
14.7. Fujifilm Holdings Corporation
14.8. Koninklijke Philips N.V.
14.9. iCAD, Inc.
14.10. Medicalgorithmics SA